Antengene Corporation Limited 德琪醫藥有限公司
Pay for financial year ended 2022-12-31
| Name | Last position |
Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|---|
CNY '000 |
||||||||
Directors |
||||||||
| 1 | Alles, Mark John | INED | 667 | 682 | 1,349 | |||
| 2 | Chen, Kan (1981) 陳侃 | NED | ||||||
| 3 | Chin, John Francis | ED | 2,673 | 426 | 407 | 2,426 | 5,932 | |
| 4 | Liu, Yilun (1986) 劉逸倫 | NED | ||||||
| 5 | Lung, Donald Andrew 龍振國 | FD | 3,189 | 396 | 294 | 4,991 | 8,870 | |
| 6 | Lynch, Kevin Patrick (1965-01) | ED | 2,927 | 396 | 110 | 787 | 4,220 | |
| 7 | Mei, Jay 梅建明 | Ch, CEO | 5,945 | 2,745 | 816 | 5,850 | 15,356 | |
| 8 | Qian, Jing (1976) 錢晶 | INED | 367 | 91 | 458 | |||
| 9 | Tang, Sheng (1983) 唐晟 | INED | 367 | 91 | 458 | |||
| Total | 1,401 | 14,734 | 3,963 | 1,627 | 14,918 | 36,643 | ||
Main board pay history
Click on the year-end to see the pay details.
CNY'000
| Year-end | Fees | Salary & benefits |
Bonus | Retire | Share- based |
Total | |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | 1,316 | 12,980 | 3,998 | 1,293 | 11,786 | 31,373 | Report |
| 2022-12-31 | 1,401 | 14,734 | 3,963 | 1,627 | 14,918 | 36,643 | Report |
| Total | 2,717 | 27,714 | 7,961 | 2,920 | 26,704 | 68,016 |
Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy